Love the Postcall vibes and want to get involved? Now you can.

We’d love to talk to you if you either:

1. Want to summarize the latest high yield journal studies or…

2. Love finding great deals and resources for doctors.

Commitment is about an hour a week, and every stage of training is welcome. Apply here.

Staying #Up2Date 🚨

1. Buprenorphine for chronic pain

In this study of 207 patients with chronic pain on opioids (≥70 mg/d for at least 3 months), patients were randomized to either have the option to switch to buprenorphine or continue their current regimen. Both groups had similar small pain improvements (AMD: −0.59 vs. −0.50) and significant opioid reductions (AMD: −61.0 vs. −58.5 mg/d). Only 26% opted to switch. 

2. Atrial fibrillation (AF) post-stroke

In this study, an AI model used MRI data to identify high risk AF in acute ischemic stroke patients. The model detected all AF cases diagnosed by Holter monitoring, suggesting a potential association between brain ischemic lesion pattern on MRI and underlying AF. Models like these may serve as rapid screening tools for AF on stroke units. 

3. Dual antiplatelet therapy (DAPT) de-escalation

This meta-analysis of patients with acute coronary syndrome undergoing drug-eluting stent (DES) compared de-escalation from DAPT to ticagrelor monotherapy for 12 months vs. continuing DAPT. There was no difference in ischemic events (1.7% vs. 2.1%; HR, 0.85 [95% CI, 0.63–1.16]), but ticagrelor monotherapy significantly reduced major bleeding (0.8% vs. 2.5%; HR, 0.30 [95% CI, 0.21–0.45]). These benefits were consistent across STEMI, NSTEMI, and unstable angina subgroups.

Jab of Hope 💉

How one vaccine is giving cancer patients a new shot at life

What happened: A new personalized mRNA vaccine may reduce the risk of pancreatic cancer relapse. 

Why it matters: A pancreatic cancer diagnosis is a death sentence for most patients. In 2024, it was estimated to take 51,000 American lives – it’s currently the 3rd leading cause of cancer-related death in the US.

One New York cancer centre is working to change that. The study followed 16 patients who, in addition to surgery and chemotherapy, received a customized mRNA vaccine designed using their tumors. The vaccines train a patient’s immune system to fight cancer by targeting genetic mutations.

Surgeons removed each patient’s tumor and shipped it to BioNTech, which created their personalized vaccine, immunotherapy, and chemotherapy. The results were encouraging: 8 out of 16 patients had a strong immune response, and 6 stayed cancer-free for over 3 years because of long-lasting T cells. 

But: The study didn’t have a clean bill of health. Cancer reappeared in 7 patients, possibly due to their lack of spleen weakening their immune systems. While the results are promising, this vaccine is still in its early days and could take years to reach the public.

Bottom line: Practice makes perfect, and a larger trial is already underway to support these findings. Who knew the future was so close we could almost poke it?

Hot Off The Press

1: 👶🏽 Trump’s new executive order wants to make IVF more accessible and affordable in the US, while he also pushes for “radical transparency” to keep government waste on the chopping block. Critics aren’t impressed — past moves have made IVF access harder. This could spark battles in ongoing US healthcare wars, as Trump continues positioning himself as the fixer-in-chief.

2: 😠 Teens are ace at moodiness, angst, slamming doors — and feeling social pain. A new study from the University of Kent suggested that people in their 20s and 30s are particularly sensitive to embarrassment, grief, and sadness in other people, more so than adolescents or older adults. Brain activity linked to empathy does increase with age, but older adults were less likely to rate others' pain as intense — suggesting they still feel it, but don’t express it as readily.

3: 💦 If cleared, Utah will become the first state to entirely ban fluoride in water, denying cities their right to decide. For many, fluoride is the only form of dental care some people in the country receive, and the impact of its departure will affect low-income folks the most. The last hoop the bill has to jump through comes from Gov. Spencer Cox, but neither he nor his team has said anything about signing it.

4: 🍵 Turns out a nice cup of tea does more than help you relax. Researchers found that brewing tea removes a large amount of toxic metal from water. They discovered that finely black tea leaves steeped for a long time had the most impact on water quality.

Notable Numbers 🔢

$0: how much is Google paying for the content it summarizes with its AI-generated overviews. Apparently, nothing, according to Chegg, an online education company who is suing Google. They claim this AI is siphoning traffic, eroding the publishing industry, and providing low-quality, unverified answers. Google’s power in the search engine space has already been proclaimed illegal — so this case could mean another big antitrust fight over online AI.

30%: how much glyphosate (also known as the controversial herbicide Roundup) is absorbed through the skin. The science on glyphosate is still up for debate, as some studies link it to DNA damage, endocrine disruption, and even non-Hodgkin’s lymphoma in farm workers. Regulatory bodies remain divided on its carcinogenic potential. South of the border, RFK Jr. is pushing for a federal review.

50: the number of people in Congo that have died due to a mystery illness. The outbreak started in the Boloko village after 3 children ate a bat and died 48 hours later. The symptoms include fever, vomiting, and internal bleeding.

Postcall Picks

😂Laugh: at what it’s like to be in the OR for the firs time!

🤑Save: whether you live in a cold climate or want to enjoy a warm meal, Le Creuset has what you need. Shop their sale now, including their iconic Dutch oven!

👂Listen: to this week’s hilarious episode of Sawbones: A Marital Tour of Misguided Medicine. Their latest episode dives into frostbite, which seems fitting. 

Relax

First Question: Drug regimen of NRTIs, NNRTIs, PIs, and INSTIs

If you enjoyed the puzzle, challenge your physician friends and see if they can beat your time.

Image Challenge

Share Postcall, Get Rewards

Help Us Get Better